Latest Breaking News On - Imclone systems incorporated - Page 1 : comparemela.com

INOVIO Expands Executive Leadership to Prepare for Commercial Operations

PLYMOUTH MEETING, Pa., Nov. 5, 2021 /PRNewswire/  INOVIO , a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious. | November 20, 2021

INOVIO Expands Executive Leadership to Prepare for Commercial Operations

/PRNewswire/ INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from.

Form 8-K SEELOS THERAPEUTICS, For: Aug 27

Shanghai Genechem Co., Ltd. (Genechem) Announces appointment of Dr. Eric Rowinsky and Dr. Manuel Hidalgo to Scientific Advisory board, and abstract presentation at AACR 2021 on Claudin 6 Ab and K-Ras TCR-T

Share this article Share this article SHANGHAI, April 8, 2021 /PRNewswire/ Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advisory Board. Drs. Rowinsky and Hidalgo will bring their strong expertise in translational and clinical development to support Genechem s mission to bring its innovative pipeline to global markets through novel target discovery, early development in China, and global partnership.

Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer – IT Business Net

Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer GAITHERSBURG, Md., Dec. 21, 2020 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Rick Crowley to the newly created position of Executive Vice President, Chief Operations Officer. In this role, Mr. Crowley will have leadership responsibility for all operations, including Quality, Manufacturing, Supply Chain and Regulatory Affairs. He takes over manufacturing from Ben Machielse, who will continue with the company as an executive advisor to the Chief Executive Officer, supporting the development of the COVID vaccine. “Rick’s wealth of biopharmaceutical experience and record of on-time FDA approvals comes at the perfect time to help ensure that Novavax delivers on our global manufacturing mission and supply commitments,” said Stanley C. Erck, Novavax President and Ch